HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

1,3-disubstituted-4-aminopyrazolo [3, 4-d] pyrimidines, a new class of potent inhibitors for phospholipase D.

Abstract
Phospholipase D enzymes cleave lipid substrates to produce phosphatidic acid, an important precursor for many essential cellular molecules. Phospholipase D is a target to modulate cancer-cell invasiveness. This study reports synthesis of a new class of phospholipase D inhibitors based on 1,3-disubstituted-4-amino-pyrazolopyrimidine core structure. These molecules were synthesized and used to perform initial screening for the inhibition of purified bacterial phospholipase D, which is highly homologous to the human PLD1 . Initially tested with the bacterial phospholipase D enzyme, then confirmed with the recombinant human PLD1 and PLD2 enzymes, the molecules presented here exhibited inhibition of phospholipase D activity (IC50 ) in the low-nanomolar to low-micromolar range with both monomeric substrate diC4 PC and phospholipid vesicles and micelles. The data strongly indicate that these inhibitory molecules directly block enzyme/vesicle substrate binding. Preliminary activity studies using recombinant human phospholipase Ds in in vivo cell assays measuring both transphosphatidylation and head-group cleavage indicate inhibition in the mid- to low-nanomolar range for these potent inhibitory novel molecules in a physiological environment.
AuthorsAditya Kulkarni, Phong Quang, Victoriana Curry, Renee Keyes, Weihong Zhou, Hyejin Cho, Jonathan Baffoe, Béla Török, Kimberly Stieglitz
JournalChemical biology & drug design (Chem Biol Drug Des) Vol. 84 Issue 3 Pg. 270-81 (Sep 2014) ISSN: 1747-0285 [Electronic] England
PMID24641677 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2014 John Wiley & Sons A/S.
Chemical References
  • Enzyme Inhibitors
  • Micelles
  • Pyrazoles
  • Pyrimidines
  • pyrazolo(3,4-d)pyrimidine
  • phospholipase D2
  • Phospholipase D
  • phospholipase D1
Topics
  • Binding Sites
  • Catalytic Domain
  • Drug Design
  • Enzyme Inhibitors (chemical synthesis, chemistry, metabolism)
  • HEK293 Cells
  • Humans
  • Kinetics
  • Micelles
  • Molecular Dynamics Simulation
  • Phospholipase D (antagonists & inhibitors, biosynthesis, genetics, metabolism)
  • Protein Binding
  • Pyrazoles (chemical synthesis, chemistry, metabolism)
  • Pyrimidines (chemical synthesis, chemistry, metabolism)
  • Structure-Activity Relationship

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: